Similar analyses that were performed for the other three factors in DCIS patients - CCL5, TNFα and IL-1β - have shown similar trends to those obtained for CCL2, namely that the inflammatory chemokines "favored" co-expression with the inflammatory cytokines, and vice versa. The gene discussed is IL1B; the disease is ductal breast carcinoma in situ.